Radio iodine is used in treatment of
First, the core concept here is the use of radioactive iodine in medical treatment. Iodine is taken up by the thyroid gland, and when it's radioactive, it destroys thyroid tissue. This is used to reduce overactive thyroid in hyperthyroidism or to ablate remaining thyroid tissue after surgery in cancer cases.
The correct answer would be hyperthyroidism or thyroid cancer. Let's say the options include Graves' disease (a common cause of hyperthyroidism) or papillary thyroid carcinoma. The other options might be conditions like hypothyroidism, which doesn't require radio iodine, or other endocrine disorders like diabetes or Cushing's syndrome.
For the wrong options, if any of them are conditions where the thyroid doesn't take up iodine, like medullary thyroid carcinoma, that would be incorrect. Also, if an option is a non-thyroid condition, like adrenal issues, that's wrong. Each incorrect option needs a reason why it's not the right use for radio iodine.
The clinical pearl here is to remember that radio iodine is used for conditions where the thyroid is overactive or needs destruction, not for underactive or other glands. So the key point is the uptake mechanism and the therapeutic application based on that.
**Core Concept**
Radioactive iodine (I-131) is a targeted therapy for thyroid disorders. The thyroid gland actively concentrates iodine via the **sodium-iodide symporter (NIS)**, making it susceptible to destruction by beta radiation from I-131. This principle underlies its use in hyperthyroidism and thyroid cancer management.
**Why the Correct Answer is Right**
The correct answer is **Gravesβ disease** (a common cause of hyperthyroidism). I-131 is administered to destroy overactive thyroid tissue, reducing hormone production. The radiation induces apoptosis in thyroid follicular cells, decreasing thyroxine (T4) and triiodothyronine (T3) levels. It is also used in differentiated thyroid cancer to ablate residual tissue post-surgery.
**Why Each Wrong Option is Incorrect**
**Option A:** Hypothyroidism β Radioactive iodine is contraindicated in hypothyroidism, as it would exacerbate the condition.
**Option B:** Medullary thyroid carcinoma β This tumor arises from C-cells and does not express NIS, making it resistant to I-131.
**Option C:** Pheochromocytoma β A catecholamine-secreting adrenal tumor; iodine has no therapeutic role here.
**Clinical Pearl / High-Yield Fact**
Remember: *βRadio iodine targets iodine-grabbing thyroids.β* It works only in tissues expressing NIS (thyroid, benign adenomas, and differentiated cancers). Avoid using it in medullary thyroid cancer or hyp